Navigation Links
OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference
Date:2/6/2013

able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives.  OncoSec Medical's core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials. OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. More information is available at http://www.oncosec.com/.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause our results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include our ability to raise additional funding, our ability to acquire, develop or commercialize new products, uncertainties inherent in pre-clinical studies and clinical trials, unexpected new data, safety and technical issues, competition and market conditions. These and additional risks and uncertainties are more fully described in OncoSec Medical's filings with the Securities and Exchange Commission. Undue reliance should not be placed on forward look
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec Medical to Present at Noble Financial Capital Markets Ninth Annual Equity Conference on January 22
2. OncoSec Medical Announces $7.2 Million Public Offering
3. OncoSec Medical to Present Data at DNA Vaccines 2012 Conference
4. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
5. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
6. OncoSec to Present at Upcoming Healthcare and Investor Conferences
7. OncoSec Granted New Patent from China
8. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
9. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
10. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
11. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... July 4, 2015 ... eerstelijns chemotherapie voor patiënten met niet-resectabele uitgezaaide ... de progressievrije overleving in dat orgaan. ... kanker (mCRC) die alleen binnen de lever ... progressievrije overleving (PFS) in de lever dankzij ...
(Date:7/3/2015)... According to a new ... Management Market ECG, Implantable Loop Recorder, Manual Event ... Dual Chamber Pacemaker, CRT-D, CRT-P - Global Forecast ... Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices ... 2020 from $21,137.7 Million in 2015, at a ...
(Date:7/3/2015)... NEW YORK , July 3, 2015  Obsidian ... ) - an online service for the management of ... professionals announced today that PharmaShine now includes the 2014 ... Center for Medicare Services on June 30. The data ... 11.4 million transactions between industry and providers totaling $6.49 ...
Breaking Medicine Technology:Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2
... Pittsburgh -based Foundation Radiology Group (FRG), a premier provider ... strategic partnership with Acusis, a national provider of outsourced medical transcription ... , , ... Acusis delivers healthcare solutions that are designed to improve the productivity ...
... SHENZHEN, China , July 20 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International ... of medical devices worldwide, today announced that it will report its,financial ... after the U.S.,market closes on August 9, 2010 . Mindray,s ... on August 10, 2010 U.S. Eastern Time ( 8:00 ...
Cached Medicine Technology:Foundation Radiology Group Forms Strategic Partnership with Transcription Experts, Acusis 2Foundation Radiology Group Forms Strategic Partnership with Transcription Experts, Acusis 3Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010 2Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010 3
(Date:7/6/2015)... , ... July 06, 2015 , ... The Path of ... into the economic transformation associated with the U.S. economy over the past 40 years. ... with its use. In many ways, the book is a time capsule that chronicles ...
(Date:7/5/2015)... ... July 05, 2015 , ... World Patent Marketing, a vertically ... invention that effectively removes weeds without harming man and nature. , "The ... and Creative Director of World Patent Marketing. "It is projected to grow at ...
(Date:7/4/2015)... Florida (PRWEB) , ... July 04, 2015 , ... ... of Plastic Surgeons published the results of an annual member survey , ... the United States. More recently, the group broke that raw data down into ...
(Date:7/3/2015)... ... July 04, 2015 , ... The Harvest Hope Food Bank will hopefully be getting ... AlignLife offices in the area of Greenville SC are making it their mission to ... patients only. They are asking for donations from the public as well. As part of ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US cancer centers ... minimal asbestos exposure. Click here to read the complete story , just posted ... Center, Cedars Sinai Medical Center, and New York University exposed mice with a mutation ...
Breaking Medicine News(10 mins):Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2
... a subsidiary of MGT Capital Investments, Inc. (NYSE-A: ... of Computer-Aided Detection (CAD) and image analysis software, ... disease, today announces the following restructuring of its ... currently Chief Financial Officer, becomes Chief Executive Officer; ...
... Bill Would Create National Patient Registry, Increase Public ... The Coalition for Pulmonary Fibrosis (CPF) is excited ... pulmonary fibrosis (PF) advocacy program -- the introduction ... 2009 (PFREA) in the 111th Congress. The PFREA, ...
... beneath the ocean,s surface, tiny phytoplankton swimming upward in ... watery equivalent of Rod Serling,s Twilight Zone: a sharp ... single-celled organisms and sends them tumbling until a shift ... them free. , Scientists are aware of these ...
... Crestline Custom Imprinted Products, a direct marketing promotional products company, ... items. , ... Lewiston, ME (PRWEB) ... marketing promotional products company that trades on its ...
... a Use Not Approved By the Food and Drug ... in two whistleblower suits filed in the Northern District ... its parent company, Johnson & Johnson Inc., alleging that ... use not approved by the Food and Drug Administration ...
... a 40% Reduction of Intraocular Pressure at Two Years ... that it has surpassed 1000 implantation procedures with its ... intraocular pressure (IOP) for the treatment of glaucoma. ... and Founder of SOLX, "as it validates the importance ...
Cached Medicine News:Health News:Medicsight PLC Restructures Management Team 2Health News:Medicsight PLC Restructures Management Team 3Health News:Pulmonary Fibrosis Research Enhancement Act of 2009 Introduced in 111th U.S. Congress 2Health News:Pulmonary Fibrosis Research Enhancement Act of 2009 Introduced in 111th U.S. Congress 3Health News:Pulmonary Fibrosis Research Enhancement Act of 2009 Introduced in 111th U.S. Congress 4Health News:MIT research could help predict red tide 2Health News:MIT research could help predict red tide 3Health News:Crestline is the Source for Great Green Giveaways 2Health News:Crestline is the Source for Great Green Giveaways 3Health News:United States Joins Suits Against Scios and Johnson & Johnson 2Health News:United States Joins Suits Against Scios and Johnson & Johnson 3Health News:SOLX Announces 1000th Gold Shunt Implantation Milestone for Glaucoma Treatment 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: